These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 29682740)

  • 1. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.
    Sanford NN; Sher DJ; Butler S; Xu X; Ahn C; D'Amico AV; Rebbeck T; Aizer AA; Mahal BA
    JAMA Netw Open; 2019 May; 2(5):e193759. PubMed ID: 31099863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening.
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    J Clin Gastroenterol; 2017 Feb; 51(2):151-159. PubMed ID: 27380459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
    Brett J; Austoker J
    J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
    Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
    Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 14. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Identity Disparities in Cancer Screening Behaviors.
    Tabaac AR; Sutter ME; Wall CSJ; Baker KE
    Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.
    Ruffin MT; Gorenflo DW; Woodman B
    J Am Board Fam Pract; 2000; 13(1):1-10. PubMed ID: 10682879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Dueñas R
    Arch Esp Urol; 2013 May; 66(4):335-41. PubMed ID: 23676536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.